Today's five, straight off the screen: a specialty drugmaker, a rehab hospital network, a cell-storage supplier, a big-company stock fund and an AI server maker.
Amphastar makes injectable drugs and a low-blood-sugar nasal spray, and is shifting toward its own brands led by insulin copies. It dipped under last week's low today but closed near the day's high; we'll watch to see if the pullback's bounce holds.
See the Pullback →Encompass Health runs the largest U.S. network of rehab hospitals, and Medicare's payment increase for that care took effect this month. Today's close was its best since mid-August after a sideways stretch; the question now is whether buyers stay.
See Today's Close →BioLife Solutions makes the fluids that keep cells alive in storage, and cell and gene therapy makers keep buying more. Each dip since summer stopped higher, and Monday drew far heavier volume than usual; we'll watch to see if the uptrend holds.
See the Trend →Adams Diversified is a fund of large U.S. stocks that pays holders a set share of its value each quarter. It has moved sideways for weeks under its summer high and closed near the range's top, with TradingView's technical gauge alongside.
Check the Gauge →Dell makes servers, storage and PCs, and record AI server orders led it to raise its full-year sales outlook. It has won back most of its late-September pullback despite fading an early surge today; the question now is whether the recovery holds.
See the Pullback →A screened name is a higher probability, not a sure thing.
This newsletter is for informational purposes only and does not constitute financial advice. TradersPro and its contributors are not registered investment advisors. Always conduct your own due diligence before making investment decisions. Past performance is not indicative of future results.
